# Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.

> **NCT02438865** · PHASE2 · COMPLETED · sponsor: **Mansoura University** · enrollment: 74 (actual)

## Conditions studied

- Neoplasm, Ureter
- Neoplasm, Bladder

## Interventions

- **DRUG:** Immediate instillation of intravesical chemotherapy-Epirubicin-
- **DRUG:** Maintainance therapy of intravesical chemotherapy-Epirubicin-

## Key facts

- **NCT ID:** NCT02438865
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2018-05-01
- **Final completion:** 2018-05-30
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2018-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02438865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02438865, "Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02438865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*